Usana Health Sciences (USNA) Short term Debt (2014 - 2026)

Usana Health Sciences (USNA) has reported Short term Debt for 7 consecutive years, with $14.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short term Debt fell 39.13% year-over-year to $14.0 million in Q2 2026; TTM through Apr 2026 was $14.0 million, a 39.13% decrease from a year earlier, with the FY2026 full-year figure at $14.0 million, down 39.13% from the prior year.
• Short term Debt was $14.0 million for Q2 2026 at Usana Health Sciences, roughly flat from $14.0 million in the prior quarter.
• Over five years, Short term Debt peaked at $23.0 million in Q4 2024 and troughed at $786000.0 in Q4 2023.
• A 5-year average of $12.3 million and a median of $14.0 million in 2026 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt soared 2826.21% in 2024 and sank 39.13% in 2026, its largest moves.
• Over 5 years, Short term Debt stood at $10.0 million in 2022, then sank by 92.14% to $786000.0 in 2023, then jumped by 2826.21% to $23.0 million in 2024, then changed by 0.0% to $23.0 million in 2025, then sank by 39.13% to $14.0 million in 2026.
• The last three Short term Debt figures came in at $14.0 million (Q2 2026), $14.0 million (Q1 2026), and $23.0 million (Q1 2025), per Business Quant data.